InVivo Therapeutics Holdings Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 8.6%.

Top 17 shareholders own 8.28% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
5.25%	Armistice Capital LLC	163,100	US$60.3k	0%	no data
1.12%	BlackRock, Inc.	34,714	US$12.8k	0%	no data
1.01%	The Vanguard Group, Inc.	31,238	US$11.6k	7.95%	no data
0.6%	Geode Capital Management, LLC	18,677	US$6.9k	0%	no data
0.27%	Tower Research Capital LLC	8,395	US$3.1k	10.6%	no data
0.0087%	Morgan Stanley, Investment Banking and Brokerage Investments	270	US$99.8	0%	no data
0.008%	Richard Toselli	247	US$91.3	0%	no data
0.0068%	Richard Christopher	210	US$77.7	0%	no data
0.0047%	C. Merrifield	147	US$54.3	0%	no data
0.0011%	Heather Hamel	33	US$12.2	6.45%	no data
0.00077%	Wells Fargo & Company, Private Banking and Investment Banking Arm	24	US$8.8	4.35%	no data
0.00039%	Richard Roberts	12	US$4.5	0%	no data
0.00016%	Osaic Wealth, Inc. , Asset Management Arm	5	US$1.8	0%	no data
0.00006%	VIMA, LLC	2	US$0.7	0%	no data
0.00006%	Colonial Trust Advisors, Inc.	2	US$0.7	0%	no data
0.00003%	Sugarloaf Wealth Management, LLC	1	US$0.3	0%	no data
0.00003%	UBS Asset Management AG	1	US$0.3	-99%	no data